Goyang-si, South Korea

Seong Hoon Jeong

USPTO Granted Patents = 3 

Average Co-Inventor Count = 4.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Seong Hoon Jeong: A Pioneer in Therapeutic Innovations**

Introduction

Seong Hoon Jeong is a notable inventor based in Goyang-si, South Korea. With a focus on developing innovative therapeutic solutions, he has successfully secured two patents that contribute significantly to the medical field. His work emphasizes improving treatment options for various diseases, showcasing his expertise and dedication to innovative healthcare solutions.

Latest Patents

Seong Hoon Jeong's latest patents include groundbreaking advancements in pharmaceutical formulations. The first patent is for a PEGylated interferon-beta variant, which provides a composition effective in preventing or treating hyperproliferative diseases, inflammatory diseases, autoimmune diseases, or viral infectious diseases. This innovative variant demonstrates excellent anti-viral efficacy and has improved pharmacokinetic properties compared to native and non-PEGylated IFN-β variants. Furthermore, this invention offers enhanced patient convenience through better pharmacological effects and a significantly increased half-life in blood, making it a valuable therapy against various conditions.

His second patent focuses on the formulation of a modified interleukin-7 fusion protein. This pharmaceutical formulation includes a modified IL-7 protein that effectively protects against protein aggregation and offers protective effects under stress conditions, such as oxidation or agitation. This formulation has the potential to be used effectively for patient treatment, showcasing Seong Hoon Jeong's commitment to advancing medical therapies.

Career Highlights

Throughout his career, Seong Hoon Jeong has made noteworthy contributions to his field by working at prominent companies. He was employed at Genexine, Inc. and Abion Inc., where he further honed his skills in pharmaceutical innovation and research. His academic and professional accomplishments within these organizations underline his expertise in therapeutic research and product development.

Collaborations

Seong Hoon Jeong has collaborated with distinguished professionals in the industry, including his coworkers Donghoon Choi and Changyong Eun. Their combined efforts in research and development have propelled advancements in their respective projects and contributed greatly to the sectors they work in.

Conclusion

In summary, Seong Hoon Jeong's innovative patents and career contributions exemplify his role as a vital player in the field of pharmaceuticals. His work in creating effective therapeutic solutions, such as PEGylated interferon-beta variants and modified interleukin-7 fusion proteins, positions him at the forefront of medical research. As he continues to innovate, the impact of his inventions will undoubtedly enhance treatment options and improve patient outcomes in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…